Direct-acting agents help to eliminate hepatitis C in liver transplant recipients
from Infectious Disease Advisor
The introduction of direct-acting agents (DAAs) has caused a significant reduction in the percentage of liver transplant recipients for hepatitis C virus (HCV) who are viremic after surgery, according to study results published in the Journal of Clinical and Translational Hepatology.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063